KIF1A

APRIL 27, 2024

Link to Inside Edition 10 minute interview with Amanda and Emma. By ANDREA SWINDALL, First Published: 8:34 AM PDT, April 6, 2024 KIF1A Associated Neurological Disorder is a rare severe neurodegenerative disease caused by mutations in the KIF1A gene, Amanda Burrett says. Only about 550 known families have been affected. Amanda Burritt’s daughter Emma is living with one of the rarest conditions in the world.

Doctors 52

Doctors Nurses Disease Therapies 52

Codon

APRIL 27, 2024

Find us at press.asimov.

52

52

KIF1A

APRIL 27, 2024

April 28th is KIF1A Day! Join us in celebration! Topics include: Big accomplishments Treatment Accelerator Program (TAP) Fundraiser Fun KAND warrior dance video Donate to our TAP Fundraiser in honor of KIF1A Day. ~ Donate Today ~ $3,500 of $70,000 raised so far! ASCEND Enrollment Lagging We need ALL KAND warriors enrolled ASCEND is our Natural History Study.

Hospitals 52

Hospitals Treatment International Science 52

Drug Patent Watch

APRIL 27, 2024

This chart shows the pharmaceutical companies with the most spray dosed drugs. For a different perspective, see the most popular dosage types.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceuticals Drugs 59

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials